Zscaler Valuation
Is ZS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ZS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ZS * (MX$2872.01) is trading below our estimate of fair value (MX$3578.25)
Significantly Below Fair Value: ZS * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ZS *?
Other financial metrics that can be useful for relative valuation.
What is ZS *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$26.80b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 13.5x |
Enterprise Value/EBITDA | -166.7x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ZS *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 13.9x | ||
FTNT Fortinet | 8.7x | 12.1% | US$46.9b |
CRWD CrowdStrike Holdings | 27.4x | 19.1% | US$83.7b |
GEN Gen Digital | 4.1x | 2.6% | US$15.7b |
GTLB GitLab | 15.4x | 18.2% | US$8.9b |
ZS * Zscaler | 14.1x | 19.3% | Mex$26.8b |
Price-To-Sales vs Peers: ZS * is expensive based on its Price-To-Sales Ratio (14.1x) compared to the peer average (13.9x).
Price to Earnings Ratio vs Industry
How does ZS *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: ZS * is expensive based on its Price-To-Sales Ratio (14.1x) compared to the Global Software industry average (3x).
Price to Sales Ratio vs Fair Ratio
What is ZS *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 14.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ZS *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$2,872.01 | Mex$4,244.80 +47.8% | 9.2% | Mex$4,980.84 | Mex$3,536.40 | n/a | 40 |
May ’25 | Mex$2,965.50 | Mex$4,409.78 +48.7% | 9.1% | Mex$5,288.01 | Mex$3,633.38 | n/a | 41 |
Apr ’25 | Mex$3,178.00 | Mex$4,362.01 +37.3% | 8.9% | Mex$5,211.32 | Mex$3,580.68 | n/a | 40 |
Mar ’25 | Mex$3,710.00 | Mex$4,389.45 +18.3% | 9.5% | Mex$5,275.77 | Mex$3,589.22 | n/a | 39 |
Feb ’25 | Mex$4,213.70 | Mex$4,161.95 -1.2% | 12.7% | Mex$5,351.91 | Mex$3,149.19 | n/a | 41 |
Jan ’25 | n/a | Mex$3,763.58 0% | 11.0% | Mex$4,671.87 | Mex$3,057.95 | n/a | 39 |
Dec ’24 | n/a | Mex$3,517.47 0% | 8.1% | Mex$3,923.23 | Mex$2,826.78 | n/a | 38 |
Nov ’24 | n/a | Mex$3,380.91 0% | 10.1% | Mex$4,115.75 | Mex$2,456.46 | n/a | 39 |
Oct ’24 | Mex$2,642.63 | Mex$3,159.61 +19.6% | 8.9% | Mex$3,921.98 | Mex$2,340.81 | n/a | 39 |
Sep ’24 | n/a | Mex$2,876.72 0% | 12.2% | Mex$3,845.54 | Mex$2,050.96 | n/a | 39 |
Aug ’24 | Mex$2,669.79 | Mex$2,841.55 +6.4% | 12.7% | Mex$3,809.05 | Mex$2,031.49 | n/a | 38 |
Jul ’24 | n/a | Mex$2,885.96 0% | 12.6% | Mex$3,863.70 | Mex$2,060.64 | n/a | 37 |
Jun ’24 | Mex$2,380.79 | Mex$2,676.03 +12.4% | 18.3% | Mex$3,949.52 | Mex$2,106.41 | n/a | 37 |
May ’24 | Mex$1,620.00 | Mex$2,757.89 +70.2% | 18.2% | Mex$4,033.94 | Mex$2,061.79 | Mex$2,965.50 | 38 |
Apr ’24 | Mex$2,101.00 | Mex$2,937.52 +39.8% | 17.2% | Mex$4,261.68 | Mex$2,272.90 | Mex$3,178.00 | 38 |
Mar ’24 | n/a | Mex$3,050.77 0% | 18.9% | Mex$5,062.72 | Mex$2,209.19 | Mex$3,710.00 | 37 |
Feb ’24 | Mex$2,350.00 | Mex$3,093.73 +31.6% | 19.5% | Mex$5,120.78 | Mex$2,141.42 | Mex$4,213.70 | 38 |
Jan ’24 | Mex$2,080.68 | Mex$3,548.90 +70.6% | 17.2% | Mex$5,444.29 | Mex$2,672.65 | n/a | 36 |
Dec ’23 | n/a | Mex$3,826.21 0% | 15.6% | Mex$5,363.60 | Mex$2,969.13 | n/a | 35 |
Nov ’23 | Mex$3,027.48 | Mex$4,220.55 +39.4% | 11.9% | Mex$5,578.08 | Mex$3,187.47 | n/a | 35 |
Oct ’23 | n/a | Mex$4,227.65 0% | 11.6% | Mex$5,576.90 | Mex$3,286.39 | Mex$2,642.63 | 31 |
Sep ’23 | n/a | Mex$4,111.00 0% | 15.8% | Mex$6,164.78 | Mex$2,982.96 | n/a | 29 |
Aug ’23 | Mex$3,000.00 | Mex$4,169.99 +39.0% | 16.2% | Mex$6,345.33 | Mex$3,070.32 | Mex$2,669.79 | 29 |
Jul ’23 | n/a | Mex$4,141.88 0% | 16.5% | Mex$6,276.17 | Mex$3,036.86 | n/a | 31 |
Jun ’23 | Mex$3,156.00 | Mex$4,367.84 +38.4% | 28.3% | Mex$8,463.09 | Mex$2,952.24 | Mex$2,380.79 | 32 |
May ’23 | n/a | Mex$6,426.82 0% | 14.9% | Mex$8,600.26 | Mex$4,900.15 | Mex$1,620.00 | 32 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.